biosciences/J Infect Dis

Amplicon Sequencing as a Potential Surveillance Tool for Complexity of Infection and Drug Resistance Markers in Plasmodium falciparum Asymptomatic Infections.Wamae, K. Kimenyi, K. M. Osoti, V. de Laurent, Z. R. Ndwiga, L. Kharabora, O. Hathaway, N. J. Bailey, J. A. Juliano, J. J. Bejon, P. Ochola-Oyier, L. I.
J Infect Dis, (2022). 226:920-927

Entomological and Anthropological Factors Contributing to Persistent Malaria Transmission in Kenya, Ethiopia, and Cameroon.Bamou, R. Rono, M. Degefa, T. Midega, J. Mbogo, C. Ingosi, P. Kamau, A. Ambelu, A. Birhanu, Z. Tushune, K. Kopya, E. Awono-Ambene, P. Tchuinkam, T. Njiokou, F. Yewhalaw, D. Antonio Nkondjio, C. Mwangangi, J.
J Infect Dis, (2021). 223:S155-S170

Longitudinal Analysis of Infant Stool Bacteria Communities Before and After Acute Febrile Malaria and Artemether-Lumefantrine Treatment.Mandal, R. K. Crane, R. J. Berkley, J. A. Gumbi, W. Wambua, J. Ngoi, J. M. Ndungu, F. M. Schmidt, N. W.
J Infect Dis, (2019). 220:687-698

Transmission and Age Impact the Risk of Developing Febrile Malaria in Children with Asymptomatic Plasmodium falciparum Parasitemia.Wamae, K. Wambua, J. Nyangweso, G. Mwambingu, G. Osier, F. Ndung'u, F. Bejon, P. Ochola-Oyier, L. I.
J Infect Dis, (2019). 219:936-944

Human Immunization With a Polymorphic Malaria Vaccine Candidate Induced Antibodies to Conserved Epitopes That Promote Functional Antibodies to Multiple Parasite Strains.Feng, G. Boyle, M. J. Cross, N. Chan, J. A. Reiling, L. Osier, F. Stanisic, D. I. Mueller, I. Anders, R. F. McCarthy, J. S. Richards, J. S. Beeson, J. G.
J Infect Dis, (2018). 218:35-43

Detecting Malaria Hotspots: A Comparison of Rapid Diagnostic Test, Microscopy, and Polymerase Chain Reaction.Mogeni, P. Williams, T. N. Omedo, I. Kimani, D. Ngoi, J. M. Mwacharo, J. Morter, R. Nyundo, C. Wambua, J. Nyangweso, G. Kapulu, M. Fegan, G. Bejon, P.
J Infect Dis, (2017). 216:1091-1098

Declining Malaria Transmission Differentially Impacts the Maintenance of Humoral Immunity to Plasmodium falciparum in Children.Mugyenyi, C. K. Elliott, S. R. Yap, X. Z. Feng, G. Boeuf, P. Fegan, G. Osier, F. F. H. Fowkes, F. J. I. Avril, M. Williams, T. N. Marsh, K. Beeson, J. G.
J Infect Dis, (2017). 216:887-898

Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing circumsporozoite protein and ME-TRAP against controlled human malaria infection in malaria-naive individuals.Hodgson, S. H. Ewer, K. J. Bliss, C. M. Edwards, N. J. Rampling, T. Anagnostou, N. A. de Barra, E. Havelock, T. Bowyer, G. Poulton, I. D. de Cassan, S. Longley, R. Illingworth, J. J. Douglas, A. D. Mange, P. B. Collins, K. A. Roberts, R. Gerry, S. Berrie, E. Moyle, S. Colloca, S. Cortese, R. Sinden, R. E. Gilbert, S. C. Bejon, P. Lawrie, A. M. Nicosia, A. Faust, S. N. Hill, A. V.
J Infect Dis, (2015). 211:1076-86

Whole-genome scans provide evidence of adaptive evolution in Malawian Plasmodium falciparum isolates.Ocholla, H. Preston, M. D. Mipando, M. Jensen, A. T. Campino, S. MacInnis, B. Alcock, D. Terlouw, A. Zongo, I. Oudraogo, J. B. Djimde, A. A. Assefa, S. Doumbo, O. K. Borrmann, S. Nzila, A. Marsh, K. Fairhurst, R. M. Nosten, F. Anderson, T. J. Kwiatkowski, D. P. Craig, A. Clark, T. G. Montgomery, J.
J Infect Dis, (2014). 210:1991-2000

The plasma concentration of the B cell activating factor is increased in children with acute malaria.Nduati, E. Gwela, A. Karanja, H. Mugyenyi, C. Langhorne, J. Marsh, K. Urban, B. C.
J Infect Dis, (2011). 204:962-70

Effect of the pre-erythrocytic candidate malaria vaccine RTS,S/AS01E on blood stage immunity in young children.Bejon, P. Cook, J. Bergmann-Leitner, E. Olotu, A. Lusingu, J. Mwacharo, J. Vekemans, J. Njuguna, P. Leach, A. Lievens, M. Dutta, S. von Seidlein, L. Savarese, B. Villafana, T. Lemnge, M. M. Cohen, J. Marsh, K. Corran, P. H. Angov, E. Riley, E. M. Drakeley, C. J.
J Infect Dis, (2011). 204:9-18

Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.Olotu, A. I. Fegan, G. Bejon, P.
J Infect Dis, (2010). 201:970-1

Transmission-dependent tolerance to multiclonal Plasmodium falciparum infection.Farnert, A. Williams, T. N. Mwangi, T. W. Ehlin, A. Fegan, G. Macharia, A. Lowe, B. S. Montgomery, S. M. Marsh, K.
J Infect Dis, (2009). 200:1166-75

Tumor necrosis factor and lymphotoxin-alpha polymorphisms and severe malaria in African populations.Clark, T. G. Diakite, M. Auburn, S. Campino, S. Fry, A. E. Green, A. Richardson, A. Small, K. Teo, Y. Y. Wilson, J. Jallow, M. Sisay-Joof, F. Pinder, M. Griffiths, M. J. Peshu, N. Williams, T. N. Marsh, K. Molyneux, M. E. Taylor, T. E. Rockett, K. A. Kwiatkowski, D. P.
J Infect Dis, (2009). 199:569-75

Maternal HIV infection and placental malaria reduce transplacental antibody transfer and tetanus antibody levels in newborns in Kenya.Cumberland, P. Shulman, C. E. Maple, P. A. Bulmer, J. N. Dorman, E. K. Kawuondo, K. Marsh, K. Cutts, F. T.
J Infect Dis, (2007). 196:550-7

Plasmodium falciparum intercellular adhesion molecule-1-based cytoadherence-related signaling in human endothelial cells.Jenkins, N. Wu, Y. Chakravorty, S. Kai, O. Marsh, K. Craig, A.
J Infect Dis, (2007). 196:321-7

Characterization of a Plasmodium falciparum macrophage-migration inhibitory factor homologue.Cordery, D. V. Kishore, U. Kyes, S. Shafi, M. J. Watkins, K. R. Williams, T. N. Marsh, K. Urban, B. C.
J Infect Dis, (2007). 195:905-12

Plasmodium falciparum antigenic variation: relationships between in vivo selection, acquired antibody response, and disease severity.Bull, P. C. Pain, A. Ndungu, F. M. Kinyanjui, S. M. Roberts, D. J. Newbold, C. I. Marsh, K.
J Infect Dis, (2005). 192:1119-26

Sickle cell trait and the risk of Plasmodium falciparum malaria and other childhood diseases.Williams, T. N. Mwangi, T. W. Wambua, S. Alexander, N. D. Kortok, M. Snow, R. W. Marsh, K.
J Infect Dis, (2005). 192:178-86

Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya.Mwangi, T. W. Ross, A. Snow, R. W. Marsh, K.
J Infect Dis, (2005). 191:1932-9